Product image of Latanoprost Yonsung (Latanoprost) supplied by GNH India

Latanoprost Yonsung

Active Ingredient:
Latanoprost
Origin:
EU

Latanoprost Yonsung (Latanoprost)

Latanoprost, the active ingredient in Latanoprost Yonsung, is a prostaglandin analog presented as an eye‑drop solution for ocular use. It lowers intra‑ocular pressure and is prescribed for open‑angle glaucoma and ocular hypertension in adult patients, providing long‑term management to help prevent optic nerve damage.

GNH India supplies Latanoprost Yonsung as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics across global markets while adhering to stringent quality and regulatory standards. The company ensures timely delivery and supports regulatory documentation for importation.

Manufacturer / TM Owner

Yonsung Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Latanoprost is a prostaglandin analog used to reduce intra‑ocular pressure in glaucoma and ocular hypertension.

  • Open‑angle glaucoma: lowers intra‑ocular pressure to help prevent progression of optic nerve damage.
  • Ocular hypertension: reduces elevated eye pressure in patients at risk of developing glaucoma.
  • Elevated intra‑ocular pressure: provides sustained pressure reduction for long‑term management.

How It Works

  • Latanoprost is a prostaglandin F2α analog that binds to FP receptors in the ciliary body, enhancing uveoscleral outflow of aqueous humor. By remodeling extracellular matrix and increasing permeability, it facilitates drainage of fluid from the eye, leading to a decrease in intra‑ocular pressure. The effect begins within hours of a single dose and reaches a plateau after several days of consistent use, providing stable pressure control.

Side Effects

Latanoprost may cause ocular and systemic adverse reactions, most of which are mild and transient.

Common Side Effects

  • Eye redness: mild conjunctival hyperemia.
  • Eye irritation: transient burning or stinging sensation.
  • Increased eyelash growth: longer, thicker lashes.
  • Darkening of iris: gradual brownish pigmentation.

Serious or Rare Side Effects

  • Severe allergic reaction: swelling, rash, or difficulty breathing.
  • Uveitis: inflammation of the uveal tract.

Precautions & Warnings

Before prescribing Latanoprost, clinicians should consider several safety precautions.

  • Contraindication: avoid use in patients with known hypersensitivity to latanoprost or any component of the formulation.
  • Caution: monitor intra‑ocular pressure after initiation, as response may vary.
  • Interaction: avoid concurrent use with other prostaglandin analogs without medical supervision.
  • Pregnancy: safety not established; use only if potential benefit justifies potential risk.
  • Breastfeeding: unknown excretion in milk; weigh benefits against risks before prescribing.
  • Store at room temperature: keep the bottle in the original packaging, protect from light and freeze, and discard after the indicated period after opening.

Avoid Interactions

Latanoprost can interact with other ocular or systemic agents, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Non‑steroidal anti‑inflammatory eye drops: may reduce prostaglandin effect and increase intra‑ocular pressure.
  • Systemic beta‑blockers: combined pressure‑lowering may cause excessive reduction, requiring monitoring.

Moderate Interactions (Monitor Closely)

  • Carbonic anhydrase inhibitors: additive IOP‑lowering effect may increase risk of hypotony.
  • Anticholinergic eye drops: may affect tear film and comfort.
  • Herbal supplements containing prostaglandins: potential additive ocular effects.

Frequently Asked Questions

Latanoprost Yonsung is an ophthalmic solution indicated for the reduction of intra‑ocular pressure in patients with open‑angle glaucoma and ocular hypertension. By lowering eye pressure, it helps to prevent optic nerve damage and preserve visual function.

Latanoprost is a prostaglandin F2α analog that activates FP receptors in the ciliary body. This activation remodels the extracellular matrix and increases uveoscleral outflow of aqueous humor, thereby decreasing intra‑ocular pressure.

The dosing regimen for Latanoprost Yonsung is determined by the prescribing clinician. Typically, a single drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and timing should follow the prescriber’s instructions.

Safety of latanoprost during pregnancy and lactation has not been established. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by the treating physician.

To order Latanoprost Yonsung, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong IOP‑lowering efficacy. Compared with other agents such as timolol (a beta‑blocker) or bimatoprost (another prostaglandin analog), latanoprost has a favorable safety profile and is often preferred for its convenience.

Store the eye‑drop bottle at room temperature, protected from light and freezing. Keep it in the original packaging and discard any remaining solution after the recommended period once opened, typically 6 weeks, to maintain sterility and potency.

Latanoprost Yonsung is applied as an ophthalmic solution. The patient instills one drop into the affected eye(s) once daily, preferably in the evening, taking care not to touch the tip of the bottle to the eye or any other surface.

Serious adverse reactions, though rare, include severe allergic responses such as swelling, rash, or difficulty breathing, and ocular inflammation like uveitis. Patients should seek immediate medical attention if they experience any signs of a serious reaction.

Latanoprost Yonsung should be avoided in individuals with known hypersensitivity to latanoprost or any component of the formulation. It is also contraindicated in patients with active ocular infections or inflammation that could be worsened by prostaglandin therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Latanoprost

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT